Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.2M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
11.7M
-
Shares change
-
+967K
-
Total reported value, excl. options
-
$242M
-
Value change
-
-$44.7M
-
Put/Call ratio
-
1.45
-
Number of buys
-
69
-
Number of sells
-
-48
-
Price
-
$20.63
Significant Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) as of Q3 2024
151 filings reported holding CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.7M shares
of 12.2M outstanding shares and own 96.49% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LP (2.38M shares), Octagon Capital Advisors LP (1.12M shares), ORBIMED ADVISORS LLC (913K shares), BlackRock, Inc. (803K shares), VANGUARD GROUP INC (646K shares), TANG CAPITAL MANAGEMENT LLC (600K shares), STATE STREET CORP (596K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (529K shares), PRICE T ROWE ASSOCIATES INC /MD/ (326K shares), and Ikarian Capital, LLC (285K shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.